597 related articles for article (PubMed ID: 30503354)
1. Sex, Microbes, and Polycystic Ovary Syndrome.
Thackray VG
Trends Endocrinol Metab; 2019 Jan; 30(1):54-65. PubMed ID: 30503354
[TBL] [Abstract][Full Text] [Related]
2. Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study.
Zeng B; Lai Z; Sun L; Zhang Z; Yang J; Li Z; Lin J; Zhang Z
Res Microbiol; 2019; 170(1):43-52. PubMed ID: 30292647
[TBL] [Abstract][Full Text] [Related]
3. Gut Microbial Diversity in Women With Polycystic Ovary Syndrome Correlates With Hyperandrogenism.
Torres PJ; Siakowska M; Banaszewska B; Pawelczyk L; Duleba AJ; Kelley ST; Thackray VG
J Clin Endocrinol Metab; 2018 Apr; 103(4):1502-1511. PubMed ID: 29370410
[TBL] [Abstract][Full Text] [Related]
4. Exposure to a Healthy Gut Microbiome Protects Against Reproductive and Metabolic Dysregulation in a PCOS Mouse Model.
Torres PJ; Ho BS; Arroyo P; Sau L; Chen A; Kelley ST; Thackray VG
Endocrinology; 2019 May; 160(5):1193-1204. PubMed ID: 30924862
[TBL] [Abstract][Full Text] [Related]
5. Gut microbiota dysbiosis in polycystic ovary syndrome: association with obesity - a preliminary report.
Liang Y; Ming Q; Liang J; Zhang Y; Zhang H; Shen T
Can J Physiol Pharmacol; 2020 Nov; 98(11):803-809. PubMed ID: 32150694
[TBL] [Abstract][Full Text] [Related]
6. The Gut Microbiome Is Altered in a Letrozole-Induced Mouse Model of Polycystic Ovary Syndrome.
Kelley ST; Skarra DV; Rivera AJ; Thackray VG
PLoS One; 2016; 11(1):e0146509. PubMed ID: 26731268
[TBL] [Abstract][Full Text] [Related]
7. Gut Microbiota in Patients with Polycystic Ovary Syndrome: a Systematic Review.
Guo J; Shao J; Yang Y; Niu X; Liao J; Zhao Q; Wang D; Li S; Hu J
Reprod Sci; 2022 Jan; 29(1):69-83. PubMed ID: 33409871
[TBL] [Abstract][Full Text] [Related]
8. Effect of the ketogenic diet on gut microbiome composition and metabolomics in polycystic ovarian syndrome rats induced by letrozole and a high-fat diet.
Wang R; Zhao Y; Fang X; Miao C; Ren N; Chen Y; Cheng W; Zhang Q
Nutrition; 2023 Oct; 114():112127. PubMed ID: 37441825
[TBL] [Abstract][Full Text] [Related]
9. A New Approach to Polycystic Ovary Syndrome: The Gut Microbiota.
Yurtdaş G; Akdevelioğlu Y
J Am Coll Nutr; 2020; 39(4):371-382. PubMed ID: 31513473
[TBL] [Abstract][Full Text] [Related]
10. Gut Microbiota and the Polycystic Ovary Syndrome: Influence of Sex, Sex Hormones, and Obesity.
Insenser M; Murri M; Del Campo R; Martínez-García MÁ; Fernández-Durán E; Escobar-Morreale HF
J Clin Endocrinol Metab; 2018 Jul; 103(7):2552-2562. PubMed ID: 29897462
[TBL] [Abstract][Full Text] [Related]
11. Polycystic Ovary Syndrome and Endometrial Cancer: A Scoping Review of the Literature on Gut Microbiota.
Prakash A; Nourianpour M; Senok A; Atiomo W
Cells; 2022 Sep; 11(19):. PubMed ID: 36231000
[TBL] [Abstract][Full Text] [Related]
12. Letrozole treatment of pubertal female mice results in activational effects on reproduction, metabolism and the gut microbiome.
Arroyo P; Ho BS; Sau L; Kelley ST; Thackray VG
PLoS One; 2019; 14(9):e0223274. PubMed ID: 31568518
[TBL] [Abstract][Full Text] [Related]
13. Alterations in Gut Microbiome Composition and Barrier Function Are Associated with Reproductive and Metabolic Defects in Women with Polycystic Ovary Syndrome (PCOS): A Pilot Study.
Lindheim L; Bashir M; Münzker J; Trummer C; Zachhuber V; Leber B; Horvath A; Pieber TR; Gorkiewicz G; Stadlbauer V; Obermayer-Pietsch B
PLoS One; 2017; 12(1):e0168390. PubMed ID: 28045919
[TBL] [Abstract][Full Text] [Related]
14. Dietary α-Linolenic Acid-Rich Flaxseed Oil Exerts Beneficial Effects on Polycystic Ovary Syndrome Through Sex Steroid Hormones-Microbiota-Inflammation Axis in Rats.
Wang T; Sha L; Li Y; Zhu L; Wang Z; Li K; Lu H; Bao T; Guo L; Zhang X; Wang H
Front Endocrinol (Lausanne); 2020; 11():284. PubMed ID: 32670195
[TBL] [Abstract][Full Text] [Related]
15. Lactic acid bacteria alleviate polycystic ovarian syndrome by regulating sex hormone related gut microbiota.
He Y; Wang Q; Li X; Wang G; Zhao J; Zhang H; Chen W
Food Funct; 2020 Jun; 11(6):5192-5204. PubMed ID: 32441726
[TBL] [Abstract][Full Text] [Related]
16. Temporal relationship between alterations in the gut microbiome and the development of polycystic ovary syndrome-like phenotypes in prenatally androgenized female mice.
Kusamoto A; Harada M; Azhary JMK; Kunitomi C; Nose E; Koike H; Xu Z; Urata Y; Kaku T; Takahashi N; Wada-Hiraike O; Hirota Y; Koga K; Fujii T; Osuga Y
FASEB J; 2021 Nov; 35(11):e21971. PubMed ID: 34653284
[TBL] [Abstract][Full Text] [Related]
17. Effects of Yulin Tong Bu formula on modulating gut microbiota and fecal metabolite interactions in mice with polycystic ovary syndrome.
Su YN; Wang MJ; Yang JP; Wu XL; Xia M; Bao MH; Ding YB; Feng Q; Fu LJ
Front Endocrinol (Lausanne); 2023; 14():1122709. PubMed ID: 36814581
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the intestinal microbiome associated with PCOS affect the clinical phenotype.
Wang L; Zhou J; Gober HJ; Leung WT; Huang Z; Pan X; Li C; Zhang N; Wang L
Biomed Pharmacother; 2021 Jan; 133():110958. PubMed ID: 33171400
[TBL] [Abstract][Full Text] [Related]
19. The Gut Microbiome in Polycystic Ovary Syndrome and Its Association with Metabolic Traits.
Lüll K; Arffman RK; Sola-Leyva A; Molina NM; Aasmets O; Herzig KH; Plaza-Díaz J; Franks S; Morin-Papunen L; Tapanainen JS; Salumets A; Altmäe S; Piltonen TT; Org E
J Clin Endocrinol Metab; 2021 Mar; 106(3):858-871. PubMed ID: 33205157
[TBL] [Abstract][Full Text] [Related]
20. Gut Microbiome and Polycystic Ovary Syndrome: Interplay of Associated Microbial-Metabolite Pathways and Therapeutic Strategies.
Babu A; Devi Rajeswari V; Ganesh V; Das S; Dhanasekaran S; Usha Rani G; Ramanathan G
Reprod Sci; 2024 Jun; 31(6):1508-1520. PubMed ID: 38228976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
